Profile data is unavailable for this security.
About the company
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia (PSVT) with a subsequent indication to treat atrial fibrillation with rapid ventricular rate (AFib-RVR) and other cardiovascular indications.
- Revenue in USD (TTM)0.00
- Net income in USD-55.09m
- Incorporated2003
- Employees47.00
- LocationMilestone Pharmaceuticals Inc420-1111 boul. Dr.-Frederik-PhilipsMONTREAL H4M 2X6CanadaCAN
- Phone+1 (514) 336-0444
- Fax+1 (514) 336-0444
- Websitehttps://www.milestonepharma.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Earth Science Tech Inc | 5.98m | 330.94k | 72.42m | 8.00 | 239.58 | 33.55 | 136.82 | 12.10 | 0.001 | 0.001 | 0.0195 | 0.0069 | 3.16 | 11.41 | 106.07 | 747,970.00 | 17.50 | -224.84 | 42.70 | -- | 62.29 | 37.79 | 5.53 | -333.58 | 0.386 | -0.3899 | 0.1023 | -- | 243.77 | -36.31 | -111.95 | -- | -- | -- |
Spero Therapeutics Inc | 110.98m | 23.40m | 73.42m | 46.00 | 3.23 | 0.7612 | 3.10 | 0.6616 | 0.4213 | 0.4213 | 2.08 | 1.79 | 0.792 | -- | 3.96 | 2,412,565.00 | 16.70 | -35.52 | 21.73 | -41.75 | -- | -- | 21.09 | -124.40 | -- | -- | 0.00 | -- | 93.95 | 92.11 | 149.14 | -- | -- | -- |
Milestone Pharmaceuticals Inc | 0.00 | -55.09m | 75.10m | 47.00 | -- | 1.88 | -- | -- | -1.25 | -1.25 | 0.00 | 0.7498 | 0.00 | -- | -- | 0.00 | -53.21 | -48.44 | -56.51 | -51.56 | -- | -- | -- | -1,267.25 | -- | -- | 0.5592 | -- | -80.00 | -- | -2.22 | -- | 86.23 | -- |
Tiziana Life Sciences Ltd - ADR | 0.00 | -15.40m | 76.28m | 9.00 | -- | 3.87 | -- | -- | -0.1496 | -0.1496 | 0.00 | 0.1914 | 0.00 | -- | -- | 0.00 | -40.89 | -- | -50.40 | -- | -- | -- | -- | -- | -- | -2,083.71 | 0.0183 | -- | -- | -- | 34.25 | -- | -- | -- |
Bioatla Inc | 0.00 | -119.24m | 76.50m | 65.00 | -- | 1.54 | -- | -- | -2.49 | -2.49 | 0.00 | 1.03 | 0.00 | -- | -- | 0.00 | -81.18 | -48.72 | -96.07 | -57.35 | -- | -- | -- | -6,651.71 | -- | -- | 0.00 | -- | -- | -- | -15.95 | -- | -37.01 | -- |
MDxHealth SA - ADR | 75.33m | -39.90m | 76.68m | 300.00 | -- | -- | -- | 1.02 | -1.14 | -1.14 | 0.8428 | -0.0357 | 0.5528 | 11.06 | 6.95 | 251,090.00 | -29.28 | -51.62 | -33.98 | -64.72 | 62.76 | 50.88 | -52.97 | -117.64 | 1.53 | -1.54 | 1.02 | -- | 89.43 | 19.84 | 2.14 | -- | 30.13 | -- |
Precision BioSciences Inc | 57.53m | -19.99m | 77.01m | 109.00 | -- | 2.07 | -- | 1.34 | -5.50 | -7.41 | 13.76 | 5.38 | 0.2956 | -- | 47.10 | 527,807.30 | -10.27 | -35.35 | -12.94 | -44.22 | -- | -- | -34.74 | -147.50 | -- | -- | 0.3764 | -- | 94.15 | 34.96 | 41.67 | -- | -32.01 | -- |
SCYNEXIS Inc | 140.39m | 101.33m | 77.07m | 29.00 | 1.01 | 1.04 | -- | 0.549 | 2.01 | 2.01 | 2.89 | 1.96 | 1.49 | -- | 136.30 | 4,840,862.00 | 107.48 | -30.02 | 175.37 | -36.35 | 88.97 | -- | 72.18 | -86.76 | -- | 193.81 | 0.1433 | -- | 2,652.72 | 252.64 | 206.74 | -- | -- | -- |
Journey Medical Corp | 80.00m | -4.16m | 78.05m | 58.00 | -- | 8.57 | -- | 0.9757 | -0.3095 | -0.3095 | 4.13 | 0.6498 | 0.985 | 2.27 | 4.28 | 1,379,276.00 | -5.12 | -- | -17.85 | -- | 66.22 | -- | -5.20 | -- | 0.9357 | 0.4049 | 0.5773 | -- | 7.48 | -- | 87.00 | -- | -- | -- |
Checkpoint Therapeutics Inc | 68.00k | -52.32m | 78.12m | 23.00 | -- | -- | -- | 1,148.86 | -2.37 | -2.37 | 0.0028 | -0.2872 | 0.0076 | -- | -- | 2,956.52 | -585.51 | -142.43 | -- | -342.79 | -- | -- | -76,938.23 | -6,554.97 | -- | -- | -- | -- | -46.35 | -50.61 | 17.21 | -- | -- | -- |
Vor Biopharma Inc | 0.00 | -120.23m | 78.50m | 168.00 | -- | 0.6376 | -- | -- | -1.78 | -1.78 | 0.00 | 1.80 | 0.00 | -- | -- | 0.00 | -54.09 | -45.79 | -57.42 | -48.98 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -27.98 | -- | -- | -- |
Chimerix Inc | 41.00k | -82.59m | 78.65m | 72.00 | -- | 0.4518 | -- | 1,918.30 | -0.9296 | -0.9296 | 0.0005 | 1.94 | 0.0002 | -- | 0.1226 | 569.44 | -36.50 | -30.45 | -39.59 | -34.09 | 100.00 | -- | -201,443.90 | -442.93 | -- | -- | 0.00 | -- | -99.04 | -46.24 | -147.68 | -- | -13.24 | -- |
Data as of Jun 14 2024. Currency figures normalised to Milestone Pharmaceuticals Inc's reporting currency: US Dollar USD
Holder | Shares | % Held |
---|---|---|
BlackRock Financial Management, Inc.as of 31 Mar 2024 | 4.71m | 8.84% |
RTW Investments LPas of 31 Mar 2024 | 3.26m | 6.11% |
Millennium Management LLCas of 31 Mar 2024 | 2.86m | 5.36% |
Alta Fundamental Advisers LLCas of 31 Mar 2024 | 2.37m | 4.45% |
Lion Point Capital LPas of 31 Mar 2024 | 2.30m | 4.32% |
Citadel Advisors LLCas of 31 Mar 2024 | 2.25m | 4.23% |
Nantahala Capital Management LLCas of 31 Mar 2024 | 1.75m | 3.29% |
Stonepine Capital Management LLCas of 31 Mar 2024 | 1.46m | 2.75% |
Goldman Sachs & Co. LLC (Private Banking)as of 31 Mar 2024 | 1.35m | 2.54% |
Bleichroeder LPas of 31 Mar 2024 | 1.33m | 2.49% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.